Depression and anxiety in interstitial lung disease: a systematic review, meta-analysis and Mendelian randomization

Read full text
Authors: Dongru Du, Jiangyue Qin, Guangyue Zhang, Lijuan Gao, yanqiu wu, Zhenni Chen, Chun Wan, Tian Yang, Fengming Luo, Yongchun Shen
Cited by: 1
References: 49

Abstract

OBJECTIVE: To investigate the prevalence of depression and anxiety in interstitial lung disease (ILD) and reveal whether ILD is causally associated with depression and anxiety via Mendelian randomization (MR). METHODS: Eligible studies were identified and selected from Web of Science, PubMed and Scopus. The pooled prevalence of depression and anxiety in ILD, as well as the clinical characteristics of ILD with depression or anxiety, were assessed. Sensitivity analyses, subgroup analyses and meta-regression were applied for heterogeneity assessments. Data of MR analysis were derived from the UK biobank and Finngen cohort, and the inverse variance weighting approach was selected as the main approach for causality evaluation. RESULTS: = 98%), respectively. There was no significant difference in the prevalence of depression (p = 0.41) or anxiety (p = 0.39) across various subtypes of ILD. ILD patients with depression had a lower BMI (MD -2.11, 95% CI -3.82, -0.41, p = 0.02). Results of MR analysis revealed no causal associations for either the ILD-depression (OR 1.000, 95% CI 0.997, 1.003; p = 0.962) or the ILD-anxiety (OR 1.000, 95% CI 0.998, 1.002; p = 0.888) relationships. CONCLUSION: Although the prevalence of depression and anxiety were high in patients with ILD, no causal relationship was observed. Future studies are needed to investigate the intricate association between ILD and mental health.

Fields of Study & Subjects

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Inflammatory Myopathies and Dermatomyositis Chronic Obstructive Pulmonary Disease (COPD) Research

Publication details

Journal / source
Translational Psychiatry
Publisher
Springer Science and Business Media LLC
Volume
16
Issue
1
Publication date
12 February 2026
Language
EN